questionsmedicales.fr
Facteurs biologiques
Pigments biologiques
Porphyrines
Hématoporphyrines
Hématoporphyrines : Questions médicales fréquentes
Diagnostic
5
Imagerie médicale
Fluorescence
Tumeurs
Biopsie
Fluorescence
Tests diagnostiques
Porphyries
Maladies héréditaires
Diagnostic
Cancer
Diagnostic
Tumeurs
Tests sanguins
Hématoporphyrines
Diagnostic
Symptômes
5
Douleurs abdominales
Photosensibilité
Troubles neurologiques
Éruptions cutanées
Photosensibilité
Symptômes
Porphyries
Symptômes
Anxiété
Système nerveux
Maux de tête
Convulsions
Porphyries
Symptômes
Variabilité
Prévention
5
Prévention
Exposition au soleil
Crèmes solaires
Porphyries
Prévention
Médicaments
Suivi médical
Hématoporphyrines
Prévention
Éducation des patients
Prévention
Symptômes
Mode de vie
Prévention
Alimentation
Traitements
5
Photothérapie
Cancers
Traitements
Administration intraveineuse
Topique
Hématoporphyrines
Cancers
Efficacité
Hématoporphyrines
Effets secondaires
Réactions cutanées
Traitements
Médecine régénérative
Thérapie génique
Hématoporphyrines
Complications
5
Complications
Lésions cutanées
Troubles hépatiques
Hématologie
Anémie
Complications
Photosensibilité
Risques
Complications
Réversibilité
Complications
Traitements
Gestion
Complications
Suivi médical
Facteurs de risque
5
Facteurs de risque
Porphyries
Antécédents familiaux
Exposition au soleil
Facteurs de risque
Symptômes
Femmes
Facteurs de risque
Porphyries
Maladies hépatiques
Facteurs de risque
Porphyries
Stress
Facteurs de risque
Porphyries
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrines : Questions médicales les plus fréquentes",
"headline": "Hématoporphyrines : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Hématoporphyrines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-04",
"dateModified": "2026-02-22",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Hématoporphyrines"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Porphyrines",
"url": "https://questionsmedicales.fr/mesh/D011166",
"about": {
"@type": "MedicalCondition",
"name": "Porphyrines",
"code": {
"@type": "MedicalCode",
"code": "D011166",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Hématoporphyrine D",
"alternateName": "Hematoporphyrin Derivative",
"url": "https://questionsmedicales.fr/mesh/D017324",
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrine D",
"code": {
"@type": "MedicalCode",
"code": "D017324",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Éther de dihématoporphyrine",
"alternateName": "Dihematoporphyrin Ether",
"url": "https://questionsmedicales.fr/mesh/D017323",
"about": {
"@type": "MedicalCondition",
"name": "Éther de dihématoporphyrine",
"code": {
"@type": "MedicalCode",
"code": "D017323",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D23.767.727.462.400.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Hématoporphyrines",
"alternateName": "Hematoporphyrins",
"code": {
"@type": "MedicalCode",
"code": "D006415",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Guozhang Ma",
"url": "https://questionsmedicales.fr/author/Guozhang%20Ma",
"affiliation": {
"@type": "Organization",
"name": "Heilongjiang Provincial Hospital, dermatology department, Harbin City, Heilongjiang Province, China. Electronic address: maguozhang8848@163.com."
}
},
{
"@type": "Person",
"name": "Cunzhi Lin",
"url": "https://questionsmedicales.fr/author/Cunzhi%20Lin",
"affiliation": {
"@type": "Organization",
"name": "Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.. Electronic address: lindoc@126.com."
}
},
{
"@type": "Person",
"name": "Xiaoqing Xiang",
"url": "https://questionsmedicales.fr/author/Xiaoqing%20Xiang",
"affiliation": {
"@type": "Organization",
"name": "Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, China. Electronic address: xiangxiaoqing1998@163.com."
}
},
{
"@type": "Person",
"name": "Yanliang Li",
"url": "https://questionsmedicales.fr/author/Yanliang%20Li",
"affiliation": {
"@type": "Organization",
"name": "Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, China. Electronic address: liyanliang1999@126.com."
}
},
{
"@type": "Person",
"name": "Xiguang Liu",
"url": "https://questionsmedicales.fr/author/Xiguang%20Liu",
"affiliation": {
"@type": "Organization",
"name": "Heilongjiang Provincial Hospital, dermatology department, archiater, Harbin City, Heilongjiang Province, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "A pectin-based photoactivated bactericide nanosystem for achieving an improved utilization rate, photostability and targeted delivery of hematoporphyrin.",
"datePublished": "2023-06-28",
"url": "https://questionsmedicales.fr/article/37326434",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1039/d3tb00300k"
}
},
{
"@type": "ScholarlyArticle",
"name": "Efficacy of hematoporphyrin injection (HpD) photodynamic therapy in the treatment of widespread extramammary Paget's disease.",
"datePublished": "2023-06-09",
"url": "https://questionsmedicales.fr/article/37302640",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pdpdt.2023.103649"
}
},
{
"@type": "ScholarlyArticle",
"name": "Improved glucose detection limit based on phosphorescence from protected metalloporphyrin triplet state.",
"datePublished": "2024-06-04",
"url": "https://questionsmedicales.fr/article/38879210",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.aca.2024.342825"
}
},
{
"@type": "ScholarlyArticle",
"name": "Influential Factors in the Efficacy of Hemoporfin-Mediated Photodynamic Therapy for Port-wine Stains.",
"datePublished": "2023-07-17",
"url": "https://questionsmedicales.fr/article/37460668",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10103-023-03822-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hematoporphyrin derivative-mediated photodynamic techniques for the diagnosis and treatment of chordoma.",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38821238",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.pdpdt.2024.104231"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Facteurs biologiques",
"item": "https://questionsmedicales.fr/mesh/D001685"
},
{
"@type": "ListItem",
"position": 3,
"name": "Pigments biologiques",
"item": "https://questionsmedicales.fr/mesh/D010860"
},
{
"@type": "ListItem",
"position": 4,
"name": "Porphyrines",
"item": "https://questionsmedicales.fr/mesh/D011166"
},
{
"@type": "ListItem",
"position": 5,
"name": "Hématoporphyrines",
"item": "https://questionsmedicales.fr/mesh/D006415"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Hématoporphyrines - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Hématoporphyrines",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-12",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Hématoporphyrines",
"description": "Comment les hématoporphyrines sont-elles utilisées en diagnostic ?\nQuels tests impliquent les hématoporphyrines ?\nLes hématoporphyrines peuvent-elles détecter des maladies héréditaires ?\nQuel rôle jouent-elles dans le diagnostic du cancer ?\nPeut-on mesurer les niveaux d'hématoporphyrines dans le sang ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Hématoporphyrines",
"description": "Quels symptômes sont associés à une accumulation d'hématoporphyrines ?\nLes hématoporphyrines provoquent-elles des symptômes cutanés ?\nY a-t-il des symptômes spécifiques aux porphyries ?\nComment les hématoporphyrines affectent-elles le système nerveux ?\nLes symptômes varient-ils selon le type de porphyrie ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Hématoporphyrines",
"description": "Comment prévenir les effets indésirables des hématoporphyrines ?\nY a-t-il des mesures préventives pour les porphyries ?\nLes patients doivent-ils être surveillés régulièrement ?\nComment l'éducation des patients aide-t-elle ?\nLes changements de mode de vie peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Hématoporphyrines",
"description": "Quels traitements utilisent les hématoporphyrines ?\nComment les hématoporphyrines sont-elles administrées ?\nLes hématoporphyrines sont-elles efficaces contre tous les cancers ?\nY a-t-il des effets secondaires des traitements par hématoporphyrines ?\nLes hématoporphyrines sont-elles utilisées en médecine régénérative ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Hématoporphyrines",
"description": "Quelles complications peuvent survenir avec les hématoporphyrines ?\nLes hématoporphyrines peuvent-elles causer des problèmes hématologiques ?\nY a-t-il des risques de photosensibilité ?\nLes complications sont-elles réversibles ?\nComment gérer les complications liées aux hématoporphyrines ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Hématoporphyrines",
"description": "Quels sont les facteurs de risque pour les porphyries ?\nL'exposition au soleil est-elle un facteur de risque ?\nLes femmes sont-elles plus à risque ?\nLes maladies hépatiques augmentent-elles le risque ?\nLe stress peut-il être un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D006415#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment les hématoporphyrines sont-elles utilisées en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées en imagerie pour détecter des tumeurs par fluorescence."
}
},
{
"@type": "Question",
"name": "Quels tests impliquent les hématoporphyrines ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de fluorescence et des biopsies peuvent être réalisés."
}
},
{
"@type": "Question",
"name": "Les hématoporphyrines peuvent-elles détecter des maladies héréditaires ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent aider à diagnostiquer certaines porphyries héréditaires."
}
},
{
"@type": "Question",
"name": "Quel rôle jouent-elles dans le diagnostic du cancer ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles aident à localiser et à évaluer la taille des tumeurs."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les niveaux d'hématoporphyrines dans le sang ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests sanguins peuvent mesurer les niveaux d'hématoporphyrines."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont associés à une accumulation d'hématoporphyrines ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des photosensibilités et des troubles neurologiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les hématoporphyrines provoquent-elles des symptômes cutanés ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent causer des éruptions cutanées et des lésions en cas de photosensibilité."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques aux porphyries ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme l'anxiété, la dépression et des douleurs thoraciques peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Comment les hématoporphyrines affectent-elles le système nerveux ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent provoquer des maux de tête, des troubles de la mémoire et des convulsions."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de porphyrie ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque type de porphyrie présente des symptômes spécifiques et variés."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables des hématoporphyrines ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter l'exposition au soleil et utiliser des crèmes solaires peut aider."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures préventives pour les porphyries ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éviter certains médicaments et aliments peut réduire les crises de porphyrie."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils être surveillés régulièrement ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour surveiller les niveaux d'hématoporphyrines."
}
},
{
"@type": "Question",
"name": "Comment l'éducation des patients aide-t-elle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation sur les déclencheurs et les symptômes aide à prévenir les crises."
}
},
{
"@type": "Question",
"name": "Les changements de mode de vie peuvent-ils aider ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain et une alimentation équilibrée peuvent réduire les risques."
}
},
{
"@type": "Question",
"name": "Quels traitements utilisent les hématoporphyrines ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont utilisées en photothérapie pour traiter certains cancers et maladies cutanées."
}
},
{
"@type": "Question",
"name": "Comment les hématoporphyrines sont-elles administrées ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles peuvent être administrées par voie intraveineuse ou topique selon l'indication."
}
},
{
"@type": "Question",
"name": "Les hématoporphyrines sont-elles efficaces contre tous les cancers ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont principalement efficaces contre certains types de cancers, comme le cancer de la peau."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des traitements par hématoporphyrines ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets comme des douleurs au site d'injection et des réactions cutanées peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les hématoporphyrines sont-elles utilisées en médecine régénérative ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elles sont explorées pour des applications en médecine régénérative et en thérapie génique."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les hématoporphyrines ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des lésions cutanées et des troubles hépatiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les hématoporphyrines peuvent-elles causer des problèmes hématologiques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent entraîner des anémies et d'autres troubles sanguins."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de photosensibilité ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients peuvent développer une photosensibilité accrue après traitement."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être réversibles avec un traitement approprié."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications liées aux hématoporphyrines ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et des ajustements de traitement sont nécessaires."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les porphyries ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents familiaux, l'exposition à certains médicaments et l'alcool sont des facteurs de risque."
}
},
{
"@type": "Question",
"name": "L'exposition au soleil est-elle un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition excessive au soleil peut aggraver les symptômes des porphyries."
}
},
{
"@type": "Question",
"name": "Les femmes sont-elles plus à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines porphyries touchent plus fréquemment les femmes, surtout en âge de procréer."
}
},
{
"@type": "Question",
"name": "Les maladies hépatiques augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies hépatiques peuvent augmenter le risque de développer des porphyries."
}
},
{
"@type": "Question",
"name": "Le stress peut-il être un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress physique ou émotionnel peut déclencher des crises de porphyrie."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 22/02/2026
Contenu vérifié selon les dernières recommandations médicales
5 publications dans cette catégorie
Affiliations :
Heilongjiang Provincial Hospital, dermatology department, Harbin City, Heilongjiang Province, China. Electronic address: maguozhang8848@163.com.
Publications dans "Hématoporphyrines" :
5 publications dans cette catégorie
Affiliations :
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.. Electronic address: lindoc@126.com.
Publications dans "Hématoporphyrines" :
4 publications dans cette catégorie
Affiliations :
Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, China. Electronic address: xiangxiaoqing1998@163.com.
Publications dans "Hématoporphyrines" :
4 publications dans cette catégorie
Affiliations :
Heilongjiang University of Chinese Medicine, Harbin City, Heilongjiang Province, China. Electronic address: liyanliang1999@126.com.
Publications dans "Hématoporphyrines" :
4 publications dans cette catégorie
Affiliations :
Heilongjiang Provincial Hospital, dermatology department, archiater, Harbin City, Heilongjiang Province, China.
Publications dans "Hématoporphyrines" :
4 publications dans cette catégorie
Affiliations :
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.. Electronic address: qdcuishichao@163.com.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Stomatology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China. Electronic address: zoeyzhang0415@163.com.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Stomatology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China. Electronic address: biliangjia6601@126.com.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Condensed Matter Science and Technology Institute, Harbin Institute of Technology, Harbin, 150080, China. Electronic address: huzheng0010@163.com.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Condensed Matter Science and Technology Institute, Harbin Institute of Technology, Harbin, 150080, China; Department of Mathematics and Materials Research Institute, The Pennsylvania State University, University Park, PA, 16802, USA. Electronic address: caowenwu808@163.com.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, Sichuan, 610041, People's Republic of China.
Publications dans "Hématoporphyrines" :
3 publications dans cette catégorie
Affiliations :
Department of Respiration, The Affiliated Hospital of Qingdao University, Qingdao, 266003, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Radiation Oncology, Harbin Medical University Cancer Hospital, Harbin, 150081, Heilongjiang, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Medical Oncology, Harbin Medical University Cancer Hospital, No. 150 Haping Road, Nangang District, Harbin, 150081, Heilongjiang, China. Yuuny_HTH@hotmail.com.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Stomatology, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, China; Faculty of Dentistry, Department of Oral Biological and Medical Sciences, University of British Columbia, Vancouver, BC V6T 1Z3, Canada. Electronic address: stevenchuang88@126.com.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China; Department of Medical Ultrasound, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310006, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Radiology, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
Publications dans "Hématoporphyrines" :
2 publications dans cette catégorie
Affiliations :
Department of Interventional and Vascular Surgery, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China; State Key Laboratory for Modification of Chemical Fibers and Polymer Materials, College of Materials Science and Engineering, Donghua University, Shanghai 201620, China. Electronic address: zgchen@dhu.edu.cn.
Publications dans "Hématoporphyrines" :
Photoactivated pesticides have many advantages, such as high activity, low toxicity, and no drug resistance. However, poor photostability and a low utilization rate limit their practical application. ...
Photodynamic therapy (PDT) utilizing Hematoporphyrin Derivative (HpD) injection has been demonstrated as an efficacious treatment for various conditions, including Bowen's disease, subtypes of basal c...
Non-invasive indirect blood glucose monitoring can be realized by detecting low concentrations of glucose (0.05-5 mM) in tears, but sensitive optical indicators are required. The intensity of the phos...
To improve the glucose detection limit of Pd-HMME phosphorescence-based methods, the triplet protector imidazole was introduced, and strong phosphorescence was observed under ambient oxygen conditions...
These results indicate the potential of the developed optical indicator for fast, selective, and reliable low-concentration glucose sensing....
Hemoporfin-mediated photodynamic therapy (HMME-PDT) is commonly used in the treatment of port-wine stains (PWS). However, the influential factors for the efficacy of the treatment are not well defined...
Chordoma is a rare congenital low-grade malignant tumor characterized by infiltrative growth. It often tends to compress important intracranial nerves and blood vessels, making its surgical treatment ...
The photosensitizer hematoporphyrin derivative (HPD) and Two different chordoma cell lines (U-CH1, JHC7) were used for the test. The in vitro experiments were as follows: (1) the fluorescence intensit...
(1) The photosensitizers in chordoma cells and chordoma xenografts of nude mice were excited by 405nm to emit red fluorescence; (2) 630 nm excitation photosensitizer reduces chordoma cell activity and...
Photodynamic techniques mediated by the photosensitizer hematoporphyrin derivatives can be used for the diagnosis and treatment of chordoma....
Pathological scars result from abnormal wound healing and represent a fibrotic process in the repair of skin injuries. Post-burn scars are prone to malignant transformation, especially when ulceration...
Paget's disease of the perianal skin (PPD) is a rare form of extramammary Paget's disease, which can manifest as either a primary intraepithelial adnexal neoplasm or as a secondary condition resulting...
Sonodynamic therapy (SDT) has emerged as a useful approach for tumor treatment. However, its widespread application is impeded by poor pharmacokinetics of existing sonosensitizers. Here we developed a...
Hematoporphyrin derivatives (HPD)-Photodynamic therapy (PDT) in combination with cisplatin (DDP) is an effective anticancer strategy. However, whether the order of combination affects efficacy has not...
The human lung adenocarcinoma (LUAD) A549 cells were used as the study subjects. After A549 cells were treated with a single medication (PDT/DDP) or a sequential combination (PDT + DDP / DDP + PDT), t...
A synergistic impact between HPD-PDT and DDP was found. The cell viability in the PDT+DDP group was significantly lower than in the DDP+PDT group. A significant apoptotic profile and a high apoptotic ...
The order of the combination therapy (PDT + DDP / DDP + PDT) was important. The HPD-PDT followed by DDP significantly inhibited LUAD cell viability, which may be related to the mitochondrial apoptotic...
Cutaneous squamous cell carcinoma (cSCC) is a prevalent malignant tumor typically treated through surgical removal. However, when the lesion is situated in specific areas like the hands, feet, or lips...